Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The commonly referenced "plastoquinone-binding protein in photosystem II" does not correspond to a single, well-defined protein but rather refers to the binding sites within the photosystem II (PSII) protein complex where plastoquinone molecules (specifically, QA and QB) are coordinated. PSII is a multi-subunit pigment-protein complex embedded in the thylakoid membranes of cyanobacteria, algae, and higher plants, where it catalyzes the light-driven oxidation of water, resulting in oxygen evolution and electron transfer through the photosynthetic electron transport chain[1][3][5]. **Plastoquinone** (PQ) acts as a mobile electron carrier and binds at distinct sites (notably QA and QB) on the PSII reaction center. The QA site binds PQ tightly for one-electron transfer, while the QB site binds PQ more loosely, enabling two-electron transfers and subsequent protonation to form plastoquinol (PQH2), which is released into the membrane pool to continue electron transport[2][3]. Additional sites (e.g., QC, QD) have been described, but are less characterized and may serve roles in PQ exchange or photoprotection[1][3][4]. The proteins directly coordinating these PQ binding sites are usually subunits of PSII such as D1 (PsbA) and D2 (PsbD)[1][2][3]. There isn’t a canonical "plastoquinone-binding protein" as a stand-alone entity or therapeutic target; these are integral domains of PSII structural proteins. Accordingly, this is not a therapeutic target or druggable protein, and does not have interacting drugs, associated diseases, recognized biomarkers, or safety concerns in the biomedical sense. **Key caveat:** The term "plastoquinone-binding protein in photosystem II" is non-standard and does not map to a single, canonical protein or molecular target. For scientific and biomedical purposes, refer specifically to PSII subunits (such as D1/PsbA and D2/PsbD) for molecular targeting, or to the PSII complex as a whole in the context of biochemical or structural studies[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plastoquinone-binding protein in photosystem II.